ARDT
Ardent Health·NYSE
--
--(--)
--
--(--)
ARDT fundamentals
During Q4 2025, Ardent Health (ARDT) reported revenue of 1.61B, a YoY change of -0.08%. Net income was 74.26M, a YoY change of -47.29%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2017 | Q4,2017 | Q3,2018 | Q4,2018 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jul 1, 2017 | Oct 1, 2017 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Sep 30, 2017 | Dec 31, 2017 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 782.10M -- | 849.77M -- | 1.09B +39.28% | 1.09B +28.60% | 1.32B -- | 1.37B -- | 1.38B -- | 1.35B -- | 1.44B +9.27% | 1.47B +7.47% | 1.45B +5.23% | 1.61B +19.33% | 1.50B +4.04% | 1.65B +11.85% | 1.58B +8.75% | 1.61B -0.08% | 6.32B -- |
Sales and Services Revenue | 770.45M -- | 839.42M -- | 1.09B +41.39% | 1.09B +30.18% | 1.32B -- | 1.37B -- | 1.35B -- | 1.32B -- | 1.42B +7.53% | 1.45B +5.64% | 1.42B +4.70% | 1.58B +19.34% | 1.47B +3.88% | 1.62B +12.02% | 1.54B +8.81% | 1.57B -0.51% | 6.20B -- |
Other Revenue | 11.64M -- | 10.35M -- | -- -- | -- -- | -- -- | -- -- | 24.88M -- | 21.20M -- | 22.95M -- | 25.03M -- | 33.38M +34.15% | 25.22M +18.98% | 26.12M +13.83% | 25.63M +2.40% | 35.55M +6.51% | 32.07M +27.16% | 119.38M -- |
Cost of Revenue | 0 -- | 0 -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | 782.10M -- | 849.77M -- | 1.09B +39.28% | 1.09B +28.60% | -- -- | 1.37B -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Income | -- -- | -- -- | -- -- | -- -- | 139.00K -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- |
Operating Expenses | 762.22M -- | 807.18M -- | 1.04B +36.05% | 1.13B +40.31% | 1.27B -- | 1.28B -- | 1.31B -- | 1.32B -- | 1.36B +7.34% | 1.37B +6.76% | 1.38B +5.08% | 1.45B +9.76% | 1.43B +4.91% | 1.51B +10.16% | 1.56B +13.11% | 1.50B +3.56% | 6.00B -- |
Selling, General and Administrative Expenses | 395.92M -- | 414.81M -- | 544.99M +37.65% | 547.75M +32.05% | 1.16B -- | 632.96M -- | 880.62M -- | 870.66M -- | 656.86M -43.44% | 660.37M +4.33% | 671.99M -23.69% | 1.79B +105.47% | 693.85M +5.63% | 711.01M +7.67% | 716.12M +6.57% | 1.89B +5.37% | 4.01B -- |
Other Operating Expenses | 366.30M -- | 392.38M -- | 492.00M +34.31% | 584.85M +49.05% | 108.55M -- | 649.26M -- | 432.10M -- | 449.19M -- | 706.36M +550.70% | 708.56M +9.13% | 707.44M +63.72% | -340.22M -175.74% | 736.29M +4.24% | 796.99M +12.48% | 844.17M +19.33% | -384.75M -13.09% | 1.99B -- |
Operating Income | 19.88M -- | 42.59M -- | 52.33M +163.27% | -39.80M -193.45% | 47.12M -- | 86.51M -- | 65.01M -- | 26.19M -- | 75.83M +60.92% | 101.99M +17.89% | 70.38M +8.26% | 157.57M +501.72% | 67.09M -11.52% | 137.28M +34.61% | 16.46M -76.62% | 104.75M -33.52% | 325.58M -- |
Non-Operating Income (Loss) | -21.21M -- | -21.64M -- | -28.35M -33.63% | -28.68M -32.57% | -18.12M -- | -18.69M -- | -19.04M -- | -17.36M -- | -19.26M -6.30% | -19.80M -5.94% | -13.31M +30.09% | 9.67M +155.73% | 7.11M +136.90% | -15.29M +22.79% | -18.66M -40.18% | -12.38M -228.00% | -39.23M -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | 2.00K -- | -- -- | 0 -- | 1.09M -- | 0 -100.00% | -1.64M -- | 1.32M -- | 23.20M +2026.67% | 21.28M -- | -560.00K +65.92% | -4.75M -460.44% | 0 -100.00% | 15.98M -- |
Net Interest Expense | 21.21M -- | 21.64M -- | 28.35M +33.63% | 28.68M +32.57% | 18.12M -- | 18.69M -- | 19.04M -- | 18.45M -- | 19.26M +6.29% | 18.16M -2.85% | 14.63M -23.17% | 13.53M -26.68% | 14.18M -26.40% | 14.73M -18.89% | 13.91M -4.89% | 12.38M -8.46% | 55.20M -- |
Interest Expense | -- -- | 70.74M -- | -- -- | 113.46M +60.39% | 18.12M -- | 18.69M -- | 19.04M -- | 18.45M -- | 19.26M +6.29% | 18.16M -2.85% | 14.63M -23.17% | 13.53M -26.68% | 14.18M -26.40% | 14.73M -18.89% | 13.91M -4.89% | 12.38M -8.46% | 55.20M -- |
Pretax Income From Continuing Operations | -1.34M -- | 20.95M -- | 23.98M +1895.06% | -68.48M -426.89% | 29.00M -- | 67.82M -- | 45.97M -- | 8.83M -- | 56.56M +95.04% | 82.18M +21.18% | 57.07M +24.14% | 167.25M +1794.71% | 74.20M +31.18% | 121.99M +48.44% | -2.20M -103.86% | 92.37M -44.77% | 286.36M -- |
Income Tax Expense | -3.10M -- | 46.65M -- | 5.55M +279.23% | -4.10M -108.79% | 5.22M -- | 12.11M -- | 7.26M -- | -1.95M -- | 10.71M +105.27% | 15.22M +25.69% | 11.06M +52.35% | 26.36M +1448.77% | 15.23M +42.19% | 26.29M +72.72% | -3.41M -130.83% | 18.11M -31.29% | 56.22M -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 17.88M -- | -- -- | -- -- | -- -- | 40.07M +124.07% | -- -- | -- -- | -- -- | 12.63M -68.48% | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 4.75M -- | -- -- | -- -- | -- -- | 23.28M +389.71% | -- -- | -- -- | -- -- | 43.59M +87.25% | -- -- |
Net Income | 1.76M -- | -25.70M -- | 18.43M +947.33% | -64.38M -150.50% | 23.78M -- | 55.71M -- | 38.71M -- | 10.78M -- | 45.85M +92.80% | 66.96M +20.20% | 46.01M +18.85% | 140.89M +1206.85% | 58.97M +28.60% | 95.70M +42.92% | 1.21M -97.38% | 74.26M -47.29% | 230.13M -- |
Net Income Attributable to Minority Interests | 8.53M -- | 10.47M -- | 12.94M +51.74% | 8.10M -22.61% | 19.64M -- | 22.63M -- | 17.87M -- | 14.93M -- | 18.80M -4.25% | 24.19M +6.90% | 19.68M +10.15% | 26.69M +78.70% | 17.58M -6.50% | 22.75M -5.95% | 24.68M +25.41% | 29.31M +9.81% | 94.32M -- |
Net Income Attributable to Owners of the Company | -6.77M -- | -36.17M -- | 5.49M +181.09% | -72.48M -100.40% | 4.14M -- | 33.08M -- | 20.84M -- | -4.15M -- | 27.05M +552.84% | 42.77M +29.31% | 26.32M +26.32% | 114.20M +2849.92% | 41.38M +53.00% | 72.95M +70.56% | -23.48M -189.20% | 44.96M -60.64% | 135.81M -- |
Net Income Attributable to Common Stockholders | -6.77M -- | -36.17M -- | 5.49M +181.09% | -72.48M -100.40% | 4.14M -- | 33.08M -- | 20.84M -- | -4.15M -- | 27.05M +552.84% | 42.77M +29.31% | 26.32M +26.32% | 114.20M +2849.92% | 41.38M +53.00% | 72.95M +70.56% | -23.48M -189.20% | 44.96M -60.64% | 135.81M -- |
Other Comprehensive Income | 0 -- | 0 -- | 1.45M -- | -7.34M -- | -4.56M -- | 4.59M -- | 31.00K -- | -8.03M -- | 703.00K +115.40% | -2.25M -149.14% | -7.52M -24367.74% | 251.00K +103.13% | -5.81M -926.32% | -4.32M -91.75% | -2.24M +70.25% | -976.00K -488.84% | -13.35M -- |
Total Comprehensive Income | 26.48M -- | -25.70M -- | -37.49M -241.60% | -71.72M -179.06% | 19.22M -- | 60.30M -- | 38.74M -- | 2.75M -- | 46.55M +142.24% | 64.71M +7.32% | 38.48M -0.66% | 141.14M +5026.84% | 53.16M +14.18% | 91.38M +41.22% | -1.03M -102.68% | 73.29M -48.08% | 216.79M -- |
Total Comprehensive Income Attributable to Minority Interests | 25.95M -- | 10.47M -- | 31.60M +21.75% | 8.10M -22.61% | 19.64M -- | 22.63M -- | 17.87M -- | 14.93M -- | 18.80M -4.25% | 24.19M +6.90% | 19.68M +10.15% | 26.69M +78.70% | 17.58M -6.50% | 22.75M -5.95% | 24.68M +25.41% | 29.31M +9.81% | 94.32M -- |
Total Comprehensive Income Attributable to Owners of the Company | 521.00K -- | -36.17M -- | -69.09M -13360.65% | -79.82M -120.70% | -421.00K -- | 37.66M -- | 20.87M -- | -12.18M -- | 27.75M +6691.45% | 40.52M +7.57% | 18.80M -9.92% | 114.45M +1039.62% | 35.57M +28.19% | 68.63M +69.38% | -25.72M -236.79% | 43.98M -61.57% | 122.46M -- |
Basic EPS | -- -- | -- -- | -- -- | -- -- | -- -- | 0.26 -- | 0.17 -- | -- -- | 0.21 -- | 0.34 +30.77% | 0.19 +11.76% | 0.8 -- | 0.3 +42.86% | 0.52 +52.94% | -0.17 -189.47% | 0.31 -61.25% | 0.96 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0.17 -- | -- -- | 0.21 -- | 0.34 -- | 0.19 +11.76% | -- -- | 0.3 +42.86% | 0.52 +52.94% | -0.17 -189.47% | -- -- | -- -- |
Diluted EPS | -- -- | -- -- | -- -- | -- -- | -- -- | 0.26 -- | 0.17 -- | -- -- | 0.21 -- | 0.34 +30.77% | 0.19 +11.76% | -- -- | 0.29 +38.10% | 0.52 +52.94% | -0.17 -189.47% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0.17 -- | -- -- | 0.21 -- | 0.34 -- | 0.19 +11.76% | -- -- | 0.29 +38.10% | 0.52 +52.94% | -0.17 -189.47% | -- -- | -- -- |
You can ask Aime
What is the market's earnings forecast for Ardent Health next quarter?What is the revenue and EPS growth rate for Ardent Health year over year?What guidance did Ardent Health's management provide for the next earnings period?What is Ardent Health's gross profit margin?What were the key takeaways from Ardent Health’s earnings call?What factors drove the changes in Ardent Health's revenue and profit?What is Ardent Health's latest dividend and current dividend yield?Did Ardent Health beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
